查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493386

上游生物製程市場規模、佔有率、趨勢分析報告：按產品、按工作流程、按使用類型、按模式、按地區、細分市場預測，2024-2030 年

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow, By Use Type, By Mode, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

上游生物製程市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球上游生物製程市場規模將達到592.4億美元，2024年至2030年複合年成長率為14.3%。

生物製藥的商業性成功和廣泛接受為多家專有和契約製造生物製藥公司提供了利潤豐厚的成長途徑。此外，對生物相似藥和生技藥品的高需求、推出具有成本效益的改進技術以及對一次性系統的接受度提高等因素正在共同推動市場的收益表現。

新興企業和新參與企業在建造新的生物製造工廠時經常面臨預算限制。因此，這些營業單位正在透過將製造流程委託給合約服務來擴大其生物治療產品組合，有助於增加上游生物製程服務的收益。

連續的上游生物製程為生物加工產業帶來了顯著的效益。對於反應器培養物的澄清，擴大引入聲波技術和連續離心等方法，這往往會最大限度地減少澄清的負擔。這導致更高的細胞培養密度和更有效率的上游工程。

由於細胞株在蛋白質表現和克隆篩檢方面生產力的持續進步，預計細胞培養產品在預測期內將具有最快的複合年成長率。細胞培養被認為是上游生物加工中最困難和關鍵的步驟，因此在技術複雜性方面需要更多的關注，從而佔據了上游生物加工市場的最大佔有率。

多用途系統等因素在於，這些系統需要一次性投資，利用率高，可應用於更大量的生物過程，並能準確維持pH和氧氣。然而，從傳統不銹鋼反應器到一次性反應器系統的模式轉移一直是一次性產業利潤豐厚成長的因素。

主要市場開拓參與者正在採取新產品開發、互利合作夥伴關係、協議和地理擴張等策略性舉措，以加強其在市場中的地位。例如，2019年2月，丹納赫公司達成協議，收購通用電氣生命科學公司的生物製藥業務。透過此次收購，丹納赫將 GE BioPharma 的細胞培養基、一次性技術、開發設備和消耗品添加到其現有產品組合中，擴大了其市場佔有率。

上游生物製程市場報告亮點

  • 反應器的高可用性以及主要參與者不斷推出一次性反應器正在為反應器領域帶來顯著的收益佔有率。
  • 擁有內部生物製造能力的成熟生物製藥製造公司的存在為該領域帶來了最大的收益佔有率。
  • 由於投資增加以及透過 CMO 將一次性系統整合到工廠以擴大製造能力，外包產業預計在預測期內將以最高的複合年成長率成長。
  • 北美市場佔據主導地位，2023 年佔 36.2% 的佔有率。這是生物技術持續創新以及該地區對生物製藥日益偏好的結果。此外，美國眾多生物製藥製造商的存在和大量投資也支持了成長。
  • 亞太地區是市場成長最快的地區，預計在預測期內複合年成長率為 17.4%。這是由於人們越來越認知到可用於上游工作流程中進程內控制的快速分析方法。

目錄

第1章上游生物製程市場：調查方法與範圍

第2章上游生物製程市場：執行摘要

  • 市場展望
  • 分部展望
  • 競爭考察

第3章上游生物製程市場：變數、趨勢、範圍

  • 市場體系展望
  • 市場動態
  • 上游生物製程市場分析工具

第4章上游生物製程市場：產品估算與趨勢分析

  • 細分儀表板
  • 全球上游生物製程市場產品波動分析
  • 2018-2030年全球上游生物製程市場規模及趨勢分析（依產品）
  • 反應器/發酵罐
  • 細胞培養產品
  • 篩選
  • 反應器器配件
  • 袋子和容器
  • 其他

第5章上游生物製程市場：工作流程估計與趨勢分析

  • 細分儀表板
  • 全球上游生物製程市場工作流程變化分析
  • 2018-2030 年全球上游生物製程市場規模與趨勢分析（依工作流程）
  • 培養基製備
  • 細胞培養
  • 細胞分離

第6章上游生物製程市場：使用類型估計與趨勢分析

  • 細分儀表板
  • 全球上游生物製程市場使用類型變化分析
  • 2018-2030 年全球上游生物製程市場規模及趨勢分析（依使用類型）
  • 多次使用
  • 一次使用

第7章上游生物製程市場：模式估計與趨勢分析

  • 細分儀表板
  • 全球上游生物製程市場模式波動分析
  • 2018-2030年全球上游生物製程市場規模及趨勢分析（分模式）
  • 公司內部
  • 外包

第8章上游生物製程市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018-2030年北美市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018年至2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018年至2030年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Corning Incorporated
    • Sartorius AG
    • Eppendorf AG
    • Danaher
    • Boehringer Ingelheim GmbH
    • Applikon Biotechnology
    • PBS Biotech, Inc.
    • Lonza
    • VWR International, LLC
    • Meissner Filtration Products, Inc.
    • Repligen Corporation
    • Entegris
    • Kuhner AG
Product Code: GVR-3-68038-592-2

Upstream Bioprocessing Market Growth & Trends:

The global upstream bioprocessing market size is expected to reach USD 59.24 billion by 2030, registering a CAGR of 14.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher's market presence with the addition of GE Biopharma's cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Upstream Bioprocessing Market Report Highlights:

  • High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
  • Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
  • The outsourced segment is expected to grow at the highest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
  • North America dominated the market and accounted for a share of 36.2% in 2023 as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
  • Asia Pacific is expected to be the fastest-growing region in the market and is expected to grow at a CAGR of 17.4% during the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Table of Contents

Chapter 1. Upstream Bioprocessing Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Workflow
    • 1.1.3. Use Type
    • 1.1.4. Mode
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Upstream Bioprocessing Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Workflow outlook
    • 2.2.3. Use type outlook
    • 2.2.4. Mode outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Upstream Bioprocessing Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Upstream Bioprocessing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Upstream Bioprocessing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Upstream Bioprocessing Market Product Movement Analysis
  • 4.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Bioreactors/Fermenters
    • 4.4.1. Bioreactors/fermenters market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Cell Culture Products
    • 4.5.1. Cell Culture Products market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Filters
    • 4.6.1. Filters market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Bioreactors Accessories
    • 4.7.1. Bioreactors accessories market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Bags & Containers
    • 4.8.1. Bags & containers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Upstream Bioprocessing Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Upstream Bioprocessing Market Workflow Movement Analysis
  • 5.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Media Preparation
    • 5.4.1. Media preparation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Cell Culture
    • 5.5.1. Cell culture market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Cell Separation
    • 5.6.1. Cell separation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Upstream Bioprocessing Market: Use Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Upstream Bioprocessing Market Use Type Movement Analysis
  • 6.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Use Type, 2018 to 2030 (USD Million)
  • 6.4. Multi-use
    • 6.4.1. Multi-use market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Single-use
    • 6.5.1. Single-use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Upstream Bioprocessing Market: Mode Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Upstream Bioprocessing Market Mode Movement Analysis
  • 7.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
  • 7.4. In-house
    • 7.4.1. In-house market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Outsourced
    • 7.5.1. Outsourced market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Regulatory framework
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Canada market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Regulatory framework
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Regulatory framework
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Regulatory framework
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. France market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Regulatory framework
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Regulatory framework
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Regulatory framework
    • 8.5.7. Denmark
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Regulatory framework
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Regulatory framework
    • 8.5.9. Sweden
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Regulatory framework
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Japan market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Regulatory framework
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. China market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Regulatory framework
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. India market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Regulatory framework
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Australia market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Regulatory framework
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Regulatory framework
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Regulatory framework
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Regulatory framework
    • 8.7.3. Mexico
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Regulatory framework
    • 8.7.4. Argentina
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Regulatory framework
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Regulatory framework
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Regulatory framework
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. UAE market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Regulatory framework
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Regulatory framework

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Corning Incorporated
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Sartorius AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Eppendorf AG
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Danaher
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Boehringer Ingelheim GmbH
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Applikon Biotechnology
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. PBS Biotech, Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Lonza
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. VWR International, LLC
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Meissner Filtration Products, Inc.
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Repligen Corporation
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Entegris
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Kuhner AG
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global upstream bioprocessing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 6 Global upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 7 North America upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 10 North America upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 11 North America upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 12 U.S. upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 14 U.S. upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 15 U.S. upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 16 Canada upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Canada upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 19 Canada upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 20 Europe upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Europe upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 24 Europe upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 25 Germany upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Germany upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 28 Germany upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 29 UK upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 31 UK upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 32 UK upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 33 France upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 34 France upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 35 France upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 36 France upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 37 Italy upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 Italy upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 40 Italy upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 41 Spain upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Spain upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 44 Spain upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 45 Denmark upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 47 Denmark upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 48 Denmark upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 49 Norway upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Norway upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Norway upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 52 Norway upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 53 Sweden upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 55 Sweden upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 56 Sweden upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 62 China upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 63 China upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 64 China upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 65 China upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 66 Japan upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Japan upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 69 Japan upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 70 India upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 71 India upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 India upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 73 India upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 74 South Korea upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 76 South Korea upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 77 South Korea upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 78 Australia upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Australia upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 81 Australia upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 82 Thailand upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Thailand upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 85 Thailand upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 86 Latin America upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 88 Latin America upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 89 Latin America upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 90 Latin America upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 91 Brazil upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Brazil upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 94 Brazil upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 95 Mexico upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 96 Mexico upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 97 Mexico upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 98 Mexico upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 99 Argentina upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 101 Argentina upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 102 Argentina upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 103 MEA upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 MEA upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 107 MEA upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 108 South Africa upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Africa upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 111 South Africa upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 116 UAE upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 118 UAE upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 119 UAE upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 120 Kuwait upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Kuwait upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Upstream bioprocessing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market snapshot
  • Fig. 13 Segment snapshot 1
  • Fig. 14 Segment snapshot 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Biotechnology market value, 2023 (USD billion)
  • Fig. 17 Market trends & outlook
  • Fig. 18 PESTEL analysis
  • Fig. 19 Porter's Five Forces analysis
  • Fig. 20 Upstream bioprocessing market: Product outlook & key takeaways
  • Fig. 21 Upstream bioprocessing market: Product movement analysis
  • Fig. 22 Global bioreactors/fermenters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell culture products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global filters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Global bioreactors accessories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global bags & containers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Upstream bioprocessing market: Workflow outlook & key takeaways
  • Fig. 29 Upstream bioprocessing market: Workflow movement analysis
  • Fig. 30 Global media preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Global cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Global cell separation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Upstream bioprocessing market: Use type outlook & key takeaways
  • Fig. 34 Upstream bioprocessing market: Use type movement analysis
  • Fig. 35 Global multi-use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Global single-use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Upstream bioprocessing market: Mode outlook & key takeaways
  • Fig. 38 Upstream bioprocessing market: Mode movement analysis
  • Fig. 39 Global in-house market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Global outsourced market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Regional marketplace outlook, 2023 & 2030 (USD Billion)
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Addressable aspects of upstream process: Sartorius AG
  • Fig. 52 Key country dynamics
  • Fig. 53 UK upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 France upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Italy upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Spain upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Norway upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Sweden upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Japan upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 China upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 India upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Australia upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Thailand upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Korea upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Brazil upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Mexico upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Argentina upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 MEA upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Africa upstream bioprocessing materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Saudi Arabia upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 UAE upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Kuwait upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Market participant categorization
  • Fig. 96 Global upstream bioprocessing market position analysis, 2023
  • Fig. 97 Strategic framework